May cyproheptadine be a treatment choice for prophylaxis of PFAPA syndrome?
Year 2020,
, 268 - 269, 04.05.2020
Arzu Ekici
Abstract
No abstract available.
References
- 1. Feder HM, Salazar JC. A clinical review of 105 patients with PFAPA (a periodic fever syndrome). Acta Paediatr 2010;99:178-84.
- 2. Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr 2013;135:15.
- 3. Stojanov S, Hoffmann F, Kéry A, Renner ED, Hartl D, Lohse P, et al. Cytokine profile in PFAPA syndrome suggests continuous inflammation and reduced anti-inflammatory response. Eur Cytokine Netw 2006;17:90-7.
- 4. Müller T, Dürk T, Blumenthal B, Grimm M, Cicko S, Panther E, et al. 5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo. PLoS One 2009;4:e6453.
- 5. Taniguchi K, Ono N, Sakai T, Ichiyama Y, Uemichi K. Response to cimetidine in a 1-year-old child with PFAPA syndrome. Turk J Pediatr 2016;58:687-9.